DK0519536T3 - Diagnostisk fremgangsmåde - Google Patents

Diagnostisk fremgangsmåde

Info

Publication number
DK0519536T3
DK0519536T3 DK92201491.5T DK92201491T DK0519536T3 DK 0519536 T3 DK0519536 T3 DK 0519536T3 DK 92201491 T DK92201491 T DK 92201491T DK 0519536 T3 DK0519536 T3 DK 0519536T3
Authority
DK
Denmark
Prior art keywords
serum
multiple sclerosis
prosomal
immunochemical
diagnostic procedure
Prior art date
Application number
DK92201491.5T
Other languages
Danish (da)
English (en)
Inventor
Klaus Scherrer
Original Assignee
Pro Soma Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Soma Sarl filed Critical Pro Soma Sarl
Application granted granted Critical
Publication of DK0519536T3 publication Critical patent/DK0519536T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Vehicle Body Suspensions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK92201491.5T 1991-06-21 1992-05-26 Diagnostisk fremgangsmåde DK0519536T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91401443 1991-06-21

Publications (1)

Publication Number Publication Date
DK0519536T3 true DK0519536T3 (da) 1995-06-06

Family

ID=8208577

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92201491.5T DK0519536T3 (da) 1991-06-21 1992-05-26 Diagnostisk fremgangsmåde

Country Status (13)

Country Link
US (1) US5472848A (sv)
EP (1) EP0519536B1 (sv)
JP (1) JP3225248B2 (sv)
KR (1) KR930000951A (sv)
AT (1) ATE118893T1 (sv)
AU (1) AU656198B2 (sv)
CA (1) CA2069546C (sv)
DE (1) DE69201463T2 (sv)
DK (1) DK0519536T3 (sv)
ES (1) ES2072083T3 (sv)
FI (1) FI104219B1 (sv)
IE (1) IE66243B1 (sv)
ZA (1) ZA923679B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092089A1 (en) * 2001-11-14 2003-05-15 Moscarello Mario Anthony Method for diagnosing multiple sclerosis and an assay therefore
AU2003282612A1 (en) * 2002-10-11 2004-05-04 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807532A (nl) * 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
US4533496A (en) * 1984-05-08 1985-08-06 Monsanto Company Method of isolating monoclonal antibodies from hybridoma cultures
FR2586814A1 (fr) * 1985-08-30 1987-03-06 Centre Nat Rech Scient Anticorps monoclonaux anti-proteines p 27 k et p 31 k de prosomes et leur application a titre de reactifs de diagnostic et/ou d'identification de cellules
US4859612A (en) * 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
JPH01309686A (ja) * 1988-06-08 1989-12-14 Otsuka Pharmaceut Co Ltd 多機能プロテアーゼ
JPH05503712A (ja) * 1990-10-11 1993-06-17 プロ―ソマ・サルル 診断方法

Also Published As

Publication number Publication date
FI922480A (fi) 1992-12-22
IE922001A1 (en) 1992-12-30
FI104219B (sv) 1999-11-30
AU1829892A (en) 1992-12-24
CA2069546A1 (en) 1992-12-22
EP0519536A1 (en) 1992-12-23
JPH0694707A (ja) 1994-04-08
ES2072083T3 (es) 1995-07-01
IE66243B1 (en) 1995-12-13
US5472848A (en) 1995-12-05
AU656198B2 (en) 1995-01-27
EP0519536B1 (en) 1995-02-22
DE69201463T2 (de) 1995-06-14
CA2069546C (en) 2005-08-16
KR930000951A (ko) 1993-01-16
FI104219B1 (sv) 1999-11-30
FI922480A0 (fi) 1992-05-29
ATE118893T1 (de) 1995-03-15
JP3225248B2 (ja) 2001-11-05
DE69201463D1 (de) 1995-03-30
ZA923679B (en) 1993-01-27

Similar Documents

Publication Publication Date Title
GB1475125A (en) Immunological detection
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
NO160474C (no) Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener.
US4092114A (en) Indirect latex test for determination of immunoglobulins
Watanabe et al. Enzyme immunoassay for human ferritin.
GR3005971T3 (sv)
SE9600949D0 (sv) Method of diagnosing a mycobacterial disease and immunoassay kit
ES520012A0 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
DK0519536T3 (da) Diagnostisk fremgangsmåde
EP0387027A3 (en) Endometriosis diagnosis methods and reagents
ATE229037T1 (de) Monoklonaler antikörper gegen denthrombin- antithrombin iii-komplex und dessen verwendung in immunoassays
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
EP0352139A3 (en) Detecting antigens or antibodies
EP0364971A3 (en) Process for the detection of legionella antigens in body fluids and the like, as well as a test kit for performing the process
EP0040020A3 (en) Human reverse transcriptase enzyme, method for its purification, and its use in the detection of breast cancer
HK1012710A1 (en) Equipment and test for determining an antigen/antibody in a test sample
EP0141818A1 (en) Removal of self-binding and staph a cross-reactivity of anti-strep antibody
DE3781181D1 (de) Reagenz mit monoklonalantikoerpern zu bakteroides gingivalis.
Basta et al. Enzyme-linked immunosorbent assay for determination of human antibodies to group C meningococcal polysaccharide
ATE64466T1 (de) Immuntest.
JPH0547781B2 (sv)
HUT62705A (en) Method for detecting illneses by means of blood-serum test